Navigation Links
ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
Date:6/28/2012

SAN DIEGO, June 28, 2012 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, August 2, 2012, it will release its results for the fourth quarter and fiscal year ended June 30, 2012. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com. Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q4 2012 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:9:30 p.m.

London6:30 a.m.

Sydney, Australia (August 3, 2012)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:

US:

617-597-5377 Outside US:

+1 617-597-5377Conference Name:

Q4 2012 ResMed Inc. Results Conference Call  Participant Passcode:

68952697The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

US:

617-801-6888Outside US:

+1 617-801-6888Passcode:

18538587ResMed is a global leader in the development, manufacturing, and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.

Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's website at www.resmed.com.


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
2. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... May 15, 2017 Enterin Inc., a privately-held CNS ... developing novel compounds to treat Parkinson,s disease (PD), has enrolled ... a Phase 1/2a randomized, controlled, multicenter study involving patients with ... enroll 50 patients over a 9-to-12-month period. The first stage ... patients with PD. Participating sites include Denver ...
(Date:5/11/2017)... -- Thornhill Research Inc. ( Toronto, Ontario, Canada ... five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. Department ... ( Ottawa, Ontario, Canada ) to ... to patients requiring emergency medical procedures in a ... have been a longtime partner with Thornhill Research ...
Breaking Medicine Technology:
(Date:5/22/2017)... ... 2017 , ... Galena, Alaska, has a population of less than 500 people. ... was targeted to build a nuclear plant by the TOSHIBA Corporation. , In “The ... Yoder describes the journey to get power to his small town, off the electrical ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest ... James (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart ... innovation and business performance. He defines strategic roadmaps by reimagining business processes—bridging the ...
(Date:5/21/2017)... ... May 21, 2017 , ... Florida Pain Relief Group, a division ... newest location at 109 Silver Palm Ave., Melbourne, on Monday, May 22. Initially the ... opening of the Melbourne practice, PPOA operates 23 pain management clinics in Florida and ...
(Date:5/19/2017)... ... May 19, 2017 , ... A leader in ... Charlotte recently began recruitment efforts for the inaugural cohort of its online ... knowledge and expertise to approach and address the unique nuances healthcare organizations face ...
(Date:5/19/2017)... FL (PRWEB) , ... May 19, 2017 , ... ... asset protection services and retirement planning assistance to families and business owners in ... Sclerosis Society to advocate for MS sufferers and their families. , Multiple sclerosis ...
Breaking Medicine News(10 mins):